Rofecoxib (Vioxx)--the first of a new generation of NSAIDs.

Intensive & critical care nursing : the official journal of the British Association of Critical Care Nurses

Volumn 16, Issue 3, 2000, Pages 201-202

  MacConnachie, A M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

LACTONE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; ROFECOXIB; SULFONE;

ARTHRITIS; ARTICLE; CHEMICALLY INDUCED DISORDER; COST OF ILLNESS; DRUG MONITORING; DRUG UTILIZATION; ECONOMICS; GASTROINTESTINAL DISEASE; HUMAN; METHODOLOGY; NURSING; PRESCRIPTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS; COST OF ILLNESS; CYCLOOXYGENASE INHIBITORS; DRUG MONITORING; DRUG UTILIZATION; GASTROINTESTINAL DISEASES; HUMANS; LACTONES; PRESCRIPTIONS, DRUG; SULFONES;

EID: 0034211515     PISSN: 09643397     EISSN: None     Source Type: Journal    
DOI: 10.1054/iccn.2000.1585     Document Type: Article

References (0)